RTS Life Science announces new Pharmaceutical Testing Group

Automation company RTS Life Science has formed a new team comprised of US and UK engineering and sales personnel. The move comes after the recent acquisition of a Massacheusetts company and the opening of a US headquarters. According to RTS Director for inhalation automation Mark Fish, "Our new US office and base will help us better serve and support the US market with our proven automation solutions for inhaler testing. Read the company’s press release.

Share

published on

December 9-December 11: DDL 2026, Edinburgh, Scotland

April 27-30: RDD Europe 2027, Antibes, France

June 30: RespireX 2027, Boston, MA, USA